...
首页> 外文期刊>Current Pharmaceutical Design >Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
【24h】

Metal Complexes, their Cellular Targets and Potential for Cancer Therapy

机译:金属配合物,其细胞靶标和癌症治疗潜力

获取原文
获取原文并翻译 | 示例

摘要

The development of metal complexes with anticancer activity has had an enormous impact on cancer chemotherapy. The discovery of cisplatin in the 1960's represented a landmark achievement and ushered in a new era in cancer treatment. Despite the fact that cisplatin has achieved significant clinical benefit for several types of solid tumors, its effectiveness has been hampered by toxic side effects and tumor resistance that often leads to the occurrence of secondary malignancies. However, discovery and use of cisplatin have encouraged investigators to search for and develop novel non platinum-containing metal species with superior anti-cancer activity and low side effects. As examples, gallium salts and gold complexes have been evaluated in phase I and phase II trials. Copper-chelating compounds have also shown promising results in both preclinical and clinical studies. This review provides a comprehensive overview of various non platinum metal complexes and metal-chelating compounds and discusses their potential molecular targets in tumor cells and their applications in cancer therapy.
机译:具有抗癌活性的金属配合物的发展对癌症化学疗法产生了巨大影响。 1960年代顺铂的发现代表了里程碑式的成就,并开创了癌症治疗的新纪元。尽管事实上顺铂已经对几种类型的实体瘤取得了显着的临床益处,但其有效性一直受到毒性副作用和肿瘤耐药性的阻碍,该副作用经常导致继发性恶性肿瘤的发生。然而,顺铂的发现和使用鼓励研究者寻找和开发具有优异的抗癌活性和低副作用的新型不含铂的金属物质。例如,已经在I期和II期试验中评估了镓盐和金络合物。铜螯合化合物在临床前和临床研究中也显示出令人鼓舞的结果。这篇综述提供了各种非铂金属络合物和金属螯合化合物的全面概述,并讨论了它们在肿瘤细胞中的潜在分子靶标及其在癌症治疗中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号